Lena McLaughlin serves as the Principal Product Quality Leader at Amgen, where they leverage extensive biological research experience in both academic and industrial settings to develop innovative therapeutic and medical imaging strategies. Previously, they held various scientific roles, including Senior Scientist at Amgen and Scientist II at Horizon Therapeutics, focusing on analytical sciences and bioassay development. Lena's educational background includes a Doctor of Philosophy in Molecular Medicine from the University of Maryland, Baltimore, and a Bachelor of Science in Biochemistry from the University of Washington. They are skilled in molecular biology techniques, drug characterization studies, and collaboration across diverse scientific communities.
This person is not in any teams
This person is not in any offices